2691298
SCDGP · Clinical drug group packinfluenza A virus A/Norway/31694/2022 (H1N1) antigen / influenza A virus A/Thailand/8/2022 (H3N2) antigen / influenza B virus B/Austria/1359417/2021 antigen Inhalant Product
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Related concepts
Common questions
What is the RxNorm code for influenza A virus A/Norway/31694/2022 (H1N1) antigen / influenza A virus A/Thailand/8/2022 (H3N2) antigen / influenza B virus B/Austria/1359417/2021 antigen Inhalant Product?
influenza A virus A/Norway/31694/2022 (H1N1) antigen / influenza A virus A/Thailand/8/2022 (H3N2) antigen / influenza B virus B/Austria/1359417/2021 antigen Inhalant Product is coded as 2691298 in RxNorm.
What is RxNorm code 2691298?
2691298 is the RxNorm identifier for influenza A virus A/Norway/31694/2022 (H1N1) antigen / influenza A virus A/Thailand/8/2022 (H3N2) antigen / influenza B virus B/Austria/1359417/2021 antigen Inhalant Product. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2691298?
2691298 is a SCDGP (Clinical drug group pack) in RxNorm.
What is the UMLS mapping for 2691298?
2691298 maps to UMLS C5942073.